BCL11B-rearrangement, BCL11B expression, T-ALL, MPAL T/M phenotype, optical genome mapping, partner genes
Aggressive B-cell lymphoma, Unbalanced MYC rearrangement, 5ʹMYC gain/deletion, 3ʹMYC gain/deletion
Mantle cell lymphoma, optical genome mapping, CCND1 rearrangement, CCND2 rearrangement, genome complexity
Chronic myeloid leukemia, complete cytogenetic response, chronic phase, blasts phase, tyrosine kinase inhibitor, ABL1 mutation, additional chromosomal abnormality